APPLICATION
ANDA213757
TYPE
ANDA
ORIGINAL APPROVAL
2020-08-19
LATEST ACTION
2023-04-13
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued
Products
OLOPATADINE HYDROCHLORIDEDiscontinued
OLOPATADINE HYDROCHLORIDE 0.665MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2023-04-13Labeling · Supplement 1 · standardAP
2020-08-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.